Synulox RTU
|
-
|
V/NRP/02/1476
|
Zoetis Belgium S.A., Beļģija
|
QJ01CR02
|
cattle; pigs; dogs; cats
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/02/1476-01 |
|
1 |
Flakons, 100 ml |
-
|
V/NRP/02/1476-02 |
|
1 |
Flakons, 40 ml |
-
|
V/NRP/02/1476-03 |
|
12 |
Flakons, 40 ml |
-
|
V/NRP/02/1476-04 |
|
6 |
Flakons, 100 ml |
[PDF]
[PDF]
|
|
Synulox LC
|
-
|
V/MRP/98/0770
|
Zoetis Belgium S.A., Beļģija
|
QJ51RV01
|
lactating cows
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/MRP/98/0770-01 |
|
24 |
Injektors, 1 deva |
-
|
V/MRP/98/0770-02 |
|
300 |
Injektors, 1 deva |
-
|
V/MRP/98/0770-04 |
|
3 |
Injektors, 1 deva |
-
|
V/MRP/98/0770-05 |
|
12 |
Injektors, 1 deva |
-
|
|
Synulox 500 mg
|
-
|
V/NRP/09/0026
|
Zoetis Belgium S.A., Beļģija
|
QJ01CR02
|
dogs
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/09/0026-01 |
500 mg |
5 |
Blisteris, 2 tablete |
-
|
V/NRP/09/0026-02 |
500 mg |
10 |
Blisteris, 2 tablete |
-
|
V/NRP/09/0026-03 |
500 mg |
50 |
Blisteris, 2 tablete |
[PDF]
[PDF]
|
|
Synulox 50 mg
|
-
|
V/NRP/99/1027
|
Zoetis Belgium S.A., Beļģija
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/99/1027-01 |
50 mg |
1 |
Blisteris, 10 tablete |
-
|
V/NRP/99/1027-02 |
50 mg |
10 |
Blisteris, 10 tablete |
-
|
|
Synulox 250 mg
|
-
|
V/NRP/09/0025
|
Zoetis Belgium S.A., Beļģija
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/09/0025-01 |
250 mg |
1 |
Blisteris, 10 tablete |
-
|
V/NRP/09/0025-02 |
250 mg |
10 |
Blisteris, 10 tablete |
-
|
|
Synulox Tabletki 250 mg
|
-
|
V/I/25/0042
|
Zoetis Belgium S.A., Beļģija
|
QJ01CR02
|
dogs
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
tablets
|
International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Haupt Pharma Latina S.R.L., Itālija
|
Date of authorisation/renewal: |
09-Jun-2025
|
Marketing authorisation valid until: |
08-Jun-2030
|
Marketing authorisation procedure: |
I
|
Package leaflet: |
[DOCX] 09062025LI (09-Jun-2025)
|
Labelling text: |
See products section
|
Summary of product characteristics: |
-
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/I/25/0042-01 |
|
1 |
Blisteris, 10 tablete |
[PDF]
|
|
Synulox LC
|
-
|
V/I/20/0043
|
Zoetis Belgium S.A., Beļģija
|
QJ51RV01
|
lactating cows
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
intramammary suspension
|
International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate, Prednisolone
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Haupt Pharma Latina s.r.l., Itālija
|
Date of authorisation/renewal: |
11-Sep-2020
|
Marketing authorisation valid until: |
10-Sep-2025
|
Marketing authorisation procedure: |
I
|
Package leaflet: |
[DOCX] 31.05.2024 (31-May-2024)
|
Labelling text: |
See products section
|
Summary of product characteristics: |
-
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/I/20/0043-03 |
|
300 |
Injektors, 1 deva |
[PDF]
|
|
Synulox RTU
|
-
|
V/I/22/0013
|
Zoetis Belgium S.A., Beļģija
|
QJ01CR02
|
cattle; pigs; dogs; cats
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
suspension for injection
|
International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Haupt Pharma Latina S.R.L., Itālija
|
Date of authorisation/renewal: |
31-Mar-2022
|
Marketing authorisation valid until: |
30-Mar-2027
|
Marketing authorisation procedure: |
I
|
Package leaflet: |
[DOCX] 22062023_LI (22-Jun-2023)
|
Labelling text: |
See products section
|
Summary of product characteristics: |
-
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/I/22/0013-01 |
|
1 |
Flakons, 100 ml |
[PDF]
[PDF]
|
V/I/22/0013-02 |
|
6 |
Flakons, 100 ml |
-
|
|
Synulox Tabletki 50 mg
|
-
|
V/I/25/0041
|
Zoetis Belgium S.A., Beļģija
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
tablets
|
International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Haupt Pharma Latina S.R.L., Itālija
|
Date of authorisation/renewal: |
05-Jun-2025
|
Marketing authorisation valid until: |
04-Jun-2030
|
Marketing authorisation procedure: |
I
|
Package leaflet: |
[DOCX] 04062025LI (04-Jun-2025)
|
Labelling text: |
See products section
|
Summary of product characteristics: |
-
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/I/25/0041-01 |
|
1 |
Blisteris, 10 tablete |
[PDF]
|
|